Research output per year
Research output per year
Short title | SCART : Phase I/II study of oral MEK inhibitor Selumetinib (AZD6244 Hyd-Sulphate) in Combination with Highly Active Anti-Retroviral Therapy (HAART) in AIDS-associated Kaposi’s sarcoma (KS) |
---|---|
Status | Finished |
Effective start/end date | 21/03/12 → 20/12/19 |
Research output: Contribution to journal › Article › peer-review